PublizoomCall for tenders Supplies
Biosimilars Helix
Notice published in Dutch. The AI analysis summarises it for you in your language.
Tenders due closed — 13 November 2025 at 08:00
- Public buyer
- EMMAUS VZW
Mechelen - Place of performance
- 2800 zie bestek, Antwerp
not published: buyer's address - Planned end of contract
- 31 October 2029
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 9 October 2025
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Biosimilars Helix
6 lots
- epoëtine alfa 40.000IE voorgevulde spuit
- filgrastim (kortwerkend) voorgevulde spuit
- (li)pegfilgrastim (filgrastim langwerkend) voorgevulde spuit
- bevacizumab
- rituximab IV
- trastuzumab IV
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- AREGA PHARMA BVBA · 3 contracts won
- Novartis Pharma · 3 contracts won
- Mylan EPD (Entiteit van Viatris) · 2 contracts won
- MEDTRONIC BELGIUM NV · 2 contracts won
- PHILIPS BELGIUM COMMERCIAL · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- Fresenius Kabi NV/SA · 3 contracts won in 3 years
- AREGA PHARMA BVBA · 3 contracts won in 3 years
- Novartis Pharma · 3 contracts won in 3 years
- SANDOZ NV · 2 contracts won in 3 years
- BRAUN B MEDICAL NV · 2 contracts won in 3 years
- Mylan EPD (Entiteit van Viatris) · 2 contracts won in 3 years
- FRESENIUS MEDICAL CARE BELGIUM · 1 contract won in 3 years
- ORION PHARMA BENELUX · 1 contract won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| paliperidone IM en PO EMMAUS VZW · 4 June 2025 |
AREGA PHARMA BVBA | €227,000 |
| Contraststoffen EMMAUS VZW · 4 June 2025 |
Bracco BAYER NV GE HEALTHCARE GUERBET SA |
€4,837,000 |
| Aqua voor injectie, NaCl 0.9%, andere miniplasco's en magnesiumsulfaat EMMAUS VZW · 4 June 2025 |
B. Braun Medical nv Grindeks Kalceks Belgium |
€1,880,000 |
| Diverse geneesmiddelen oncologie PO voor Helixziekenhuizen EMMAUS VZW · 4 June 2025 |
EUROGENERICS SA Novartis Pharma PFIZER SA Accord Healthcare BV SANDOZ NV AREGA PHARMA BVBA Mylan EPD (Entiteit van Viatris) |
€874,780 |
| Aankoop en installatie van een immuunhematologie configuratie , met reagentia en onderhoud EMMAUS VZW · 3 June 2025 |
ORTHO-CLINICAL DIAGNOSTICS NV | €700,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 662040-2025.